Osteoarthritis research priorities: A report from a EULAR ad hoc expert committee

Annals of the Rheumatic Diseases

Volumn 73, Issue 8, 2014, Pages 1442-1445

  Conaghan, Philip G ^a   Kloppenburg, Margreet ^b   Schett, Georg ^c   Bijlsma, Johannes W J ^d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; METHOTREXATE;

ARTHRALGIA; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EUROPE; FOOT DISEASE; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; JOINT RADIOGRAPHY; MEDICAL EXPERT; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RESEARCH PRIORITY; REVIEW; SYMPTOM;

EPIDEMIOLOGY; OSTEOARTHRITIS; TREATMENT;

EUROPE; HUMANS; OSTEOARTHRITIS; RESEARCH; RHEUMATOLOGY;

EID: 84903905643     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204660     Document Type: Review

References (36)

1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.
2. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-223.
3. Levy E, Ferme A, Perocheau D, et al. Socioeconomic costs of osteoarthritis in France. Rev Rhum Ed Fr 1993;60 (6 Pt 2):63S-7S.
4. Watson M. Management of patients with osteoarthritis. Pharm J 1997;259:296-7. (Pubitemid 27380026)
5. Davidsen M, Kjoller M, Helweg-Larsen K. The Danish National Cohort Study (DANCOS). Scand J Public Health 2011;39 (7 Suppl):131-5.
6. van Saase JL, van Romunde LK, Cats A, et al. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989;48:271-80. (Pubitemid 19107329)
7. Symmons D, Mathers C, Pfleger B. Global burden of osteoarthritis in the year 2000. Report on the Global Burden of Disease, 2000.
8. Loza E, Abasolo L, Jover JA, et al. Burden of disease across chronic diseases: a health survey that measured prevalence, function, and quality of life. J Rheumatol 2008;35:159-65.
9. Danielsson L, Lindberg H. Prevalence of coxarthrosis in an urban population during four decades. Clin Orthop Relat Res 1997;342:106-10. (Pubitemid 27400809)
10. Vavken P, Dorotka R. Burden of musculoskeletal disease and its determination by urbanicity, socioeconomic status, age, and sex: Results from 14,507 subjects. Arthritis Care Res 2011;63:1558-64.
11. Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
12. National population projections, 2008-based. Office for National Statistics, UK. 2009.
13. The bone and joint decade 2000-2010 for prevention and treatment of musculo-skeletal disorders. Lund, Sweden, April 17-18, 1998. Proceedings. Acta Orthop Scand Suppl 1998;281:1-86.
14. Heilig G. The European Rural Development project http://wwwiiasaacat/ Research/ERD/indexhtml. 2002.
15. Loza E, Lopez-Gomez JM, Abasolo L, et al. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum 2009;61:158-65.
16. Jacobson L, Lindgren B. What are the costs of illness? Stockholm: Socialstyrelsen (National Board of Health and Welfare). 1996.
17. Leardini G, Salaffi F, Caporali R, et al. Direct and indirect costs of osteoarthritis of the knee. Clin Exp Rheumatol 2004;22:699-706. (Pubitemid 40045531)
18. Rabenda V, Manette C, Lemmens R, et al. Direct and indirect costs attributable to osteoarthritis in active subjects. J Rheumatol 2006;33:1152-8. (Pubitemid 43825470)
19. Department for Work and Pensions. Analytical Services Division. http://www.dwp. gov.uk
20. Le Pen C, Reygrobellet C, Gerentes I. Financial cost of osteoarthritis in France. The "COART" France study. Joint Bone Spine 2005;72:567-70. (Pubitemid 41821418)
21. National Joint Registry. 2009.
22. Garrellick G, Karrholm J, Rogmark C, et al. Swedish Hip Arthroplasty Register. Annual Report 2011.
23. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011;377:2115-26.
24. Chapple CM, Nicholson H, Baxter GD, et al. Patient characteristics that predict progression of knee osteoarthritis: a systematic review of prognostic studies. Arthritis Res Ther 2011;63:1115-25.
25. Wesseling J, Dekker J, van den Berg WB, et al. CHECK (Cohort Hip and Cohort Knee): similarities and differences with the Osteoarthritis Initiative. Ann Rheum Dis 2009;68:1413-19.
26. Nelson AE, Smith MW, Golightly YM, et al. 'Generalized osteoarthritis': a systematic review. Semin Arthritis Rheum 2013. [Epub ahead of print 31 Dec 2013]. doi: 10.1016/j.semarthrit.2013.12.007
27. Roddy E, Thomas MJ, Marshall M, et al. The population prevalence of symptomatic radiographic foot osteoarthritis in community-dwelling older adults: cross-sectional findings from the Clinical Assessment Study of the Foot. Ann Rheum Dis 2013. Published Online First 19 Nov 2013. doi: 10.1136/annrheumdis- 2013-203804
28. Karsdal MA, Bay-Jensen AC, Lories RJ, et al. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? Ann Rheum Dis 2014;73:336-48.
29. Wenham CY, Conaghan PG. Imaging the painful osteoarthritic knee joint: what have we learned? Nat Clin Pract Rheumatol 2009;5:149-58.
30. Sellam J, Berenbaum F. Is osteoarthritis a metabolic disease? Joint Bone Spine 2013;80:568-73.
31. van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage 2012;20:223-32.
32. Chu CR, Williams AA, Coyle CH, et al. Early diagnosis to enable early treatment of pre-osteoarthritis. Arthritis Res Ther 2012;14:212.
33. Lee AS, Ellman MB, Yan D, et al. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 2013;527:440-7.
34. Guermazi A, Hayashi D, Roemer FW, et al. Osteoarthritis: a review of the strengths and weaknesses of different imaging options. Rheum Dis Clin North Am 2013;39:567-91.
35. Lotz M, Martel-Pelletier J, Christiansen C, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis 2013;72:1756-63.
36. Fernandes L, Hagen KB, Bijlsma JWJ, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 2013;72:1125-35.